(Q46916592)
English
Safety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non-ST-segment elevation acute coronary syndrome: primary results of the DISPERSE
scientific article published on 23 October 2007
Statements
1 reference
Safety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non-ST-segment elevation acute coronary syndrome: primary results of the DISPERSE (English)
1 reference
1 reference
Robert A Harrington
1 reference
Håkan Emanuelsson
1 reference
Christopher P Cannon
1 reference
Steen Husted
1 reference
Benjamin M Scirica
1 reference
Gary Peters
1 reference
DISPERSE-2 Investigators
1 reference
23 October 2007
1 reference
50
1 reference
19
1 reference
1844-1851
1 reference
Identifiers
1 reference
1 reference